Clariant banks CHF 79 million of savings and wins a prize for its own AI

Clariant's prices went up 5.7% last quarter. Its margin still went down. The Swiss specialty chemicals company reported third-quarter results on 3 November and kept its full-year guidance, but the detail says a lot about where its money is going.

The numbers

Sales were CHF 968.8 million, up 5.6% in local currency, almost all of it from price. Volumes were down 0.1%. EBITDA before exceptional items fell 6.5% to CHF 151.5 million, taking the margin to 15.6% from 17.9% a year earlier.

Get Chem Data Digest every TuesdayThree-minute read. Free. One-click unsubscribe.

By business, Care Chemicals grew 6.6% in local currency and Adsorbents & Additives 6.4%. Catalysts grew 1.8%, with volumes hit by the Middle East conflict.

Guidance for 2026 is unchanged: roughly flat sales in local currency and an EBITDA margin before exceptional items of around 18%.

The cost side

Clariant's performance improvement programmes had delivered about CHF 79 million of run-rate savings by the end of September. The target is CHF 90 million for 2026 and the full CHF 100 million in 2027. Investing.com's write-up of the results slides puts the third quarter's headcount reductions at about 70 FTEs, bringing announced reductions to around 700 positions.

The build side

Here's the part that's easy to miss. Clariant's CLARITY platform, together with CLARITY Prime, its AI-powered evolution, won Best Digital Innovation at the ICIS Innovation Awards 2026. CLARITY is a digital monitoring tool for catalyst customers that gives them real-time insight into their plants. CLARITY Prime is a paid add-on that combines machine learning with first-principles process engineering.

In the same quarter, Clariant opened two R&D laboratories for its Additives business in China, able to develop additives such as flame retardants, antioxidants, light stabilisers and waxes locally. Innovation sales reached 19.0% of last-twelve-month sales, up from 18.8% in 2025.

Why it matters for R&D software

Chemical companies building their own AI products, and charging for them, is a pattern worth watching. It means more data science and digital product people inside the buyer, and a more informed buyer at the table when an outside informatics vendor pitches. It also means R&D and digital budgets are still being spent in growth areas, even while the cost programme runs. Vendors that position themselves as an accelerator for in-house teams, rather than a replacement, tend to have the easier conversation.

What it means for hiring

In our view, chemicals companies selling their own digital tools will keep hiring data scientists, process-modelling engineers and digital product managers. That competes directly with informatics vendors for the same scarce talent.
New R&D labs in China point to local technical and application roles. Vendors with customers expanding there will need Mandarin-speaking solution consultants and support staff.
With savings programmes running to 2027, account teams that can talk both cost and growth to the same buyer are the ones we'd expect to win.

Share Ask Anna about this →